The following government grants in the FederalGrants.com database contain the term small business in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Coupling, Energetics, and Dynamics of Atmospheric Regions |
47.050 |
25-510 |
| Exploratory/Developmental Research on Guillain Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (R21 - Clinical Trial Not Allowed) |
93.853 |
RFA-NS-25-025 |
| Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional) |
93.273, 93.279, 93.307, 93.393, 93.399 |
PAR-25-240 |
| Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional) |
93.273, 93.279, 93.307, 93.393, 93.399 |
PAR-25-241 |
| Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional) |
93.399, 93.853 |
PAR-25-170 |
| Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) |
93.393, 93.399 |
PAR-25-167 |
| National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) |
93.393, 93.394, 93.395, 93.399 |
PAR-25-081 |
| NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed) |
93.121 |
PAR-25-027 |
| NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional) |
93.853 |
PAR-25-133 |
| NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required) |
93.853 |
PAR-25-054 |
| Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) |
93.393, 93.399 |
PA-25-253 |
| Integrating Mental Health Care into Health Care Systems and Non-Health Settings in Low- and Middle-Income Countries (R01 Clinical Trial Optional) |
93.242, 93.393 |
PAR-25-201 |
| Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) |
93.121, 93.395, 93.396 |
PAR-25-108 |
| Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional) |
93.399 |
PAR-25-237 |
| F25AS00105: Great Lakes Fish and Wildlife Restoration Act FY 2025 |
15.688 |
F25AS00105 |
| Laboratories to Optimize Digital Health (R01 Clinical Trial Required) |
93.242 |
PAR-25-136 |
| NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed) |
93.853 |
PAR-25-234 |
| Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional) |
93.313, 93.866 |
PAR-25-219 |
| NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required) |
93.853 |
PAR-25-049 |
| Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) |
93.393, 93.399 |
PA-25-172 |
| Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional) |
93.313, 93.866 |
PAR-25-218 |
| DISRUPTIVE DC CONVERTERS FOR GRID RESILIENT INFRASTRUCTURE TO DELIVER SUSTAINABLE ENERGY SBIR/STTR (DC-GRIDS SBIR/STTR) |
81.135 |
DE-FOA-0003500 |
| Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) |
93.394, 93.395 |
PAR-25-079 |
| Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) |
93.286, 93.394, 93.395, 93.866, 93.867 |
PAR-24-325 |
| Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed) |
93.173, 93.242, 93.273, 93.866, 93.867 |
PAR-25-199 |
| Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed) |
93.173, 93.242, 93.273, 93.866, 93.867 |
PAR-25-198 |
| Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed) |
93.242 |
PAR-25-063 |
| Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) |
93.273, 93.396 |
PAR-25-221 |
| Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional) |
93.865 |
PAR-25-227 |
| Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional) |
93.121, 93.172, 93.173, 93.242, 93.273, 93.279, 93.310, 93.846, 93.853, 93.859, 93.865, 93.867 |
PAR-25-117 |
| Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed) |
93.865 |
PAR-25-146 |
| In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed) |
93.121, 93.313, 93.865 |
PAR-25-140 |
| Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) |
93.395 |
PAR-25-153 |
| Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) |
93.393 |
PAR-25-145 |
| Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) |
93.394, 93.395, 93.396 |
PAR-24-311 |
| Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) |
93.393, 93.394, 93.395 |
PAR-25-175 |
| NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed) |
93.866 |
PAR-24-321 |
| NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) |
93.866 |
PAR-25-222 |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) |
93.242, 93.866 |
PAR-25-036 |
| Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed) |
93.839, 93.847, 93.866 |
PAS-25-205 |
Search Results 241-280 of 21796
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 [Next] |
